BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
금요일, 9월 25

Pulse Biosciences Inc

PLSENASDAQ
Trade with Public
Trade with Public
$51.63
-0.20-0.39%
가까이에: Sep 25, 5:00 PM EST
$51.63
N/A
시간외: 4:35 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Pulse Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Pulse Biosciences (PLSE).

Price Target Range — 3 Quarters

Analyst Consensus — 5 Analysts

5Buy
Consensus RatingBuy# Analysts5Avg. Consensus PT$53Upside to Avg. PT+3.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →
DateFirmAnalystActionRating ChangePrice Target
Sep 23, 2026BTIGMarie ThibaultInitiateBuy$70
Sep 9, 2026Freedom Capital MarketsKeith HintonInitiateBuy$73
More with Benzinga EdgeGet Access

Analyst Ratings News

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.
Avi Kapoor

PRO
BTIG Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $70

BTIG analyst Marie Thibault initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $70.
Benzinga Newsdesk

PRO
Freedom Capital Markets Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $73

Freedom Capital Markets analyst Keith Hinton initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $73.
Benzinga Newsdesk

This Okta Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday

Top Wall Street analysts changed their outlook on top stocks. See analyst ratings and price targets for PMT, ALAB.
Avi Kapoor

This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed outlook on top names. See analyst rating changes on Benzinga's page. Analysts have positive views on ONTO stock.
Avi Kapoor

PRO
Needham Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $58

Needham analyst Mike Matson initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $58.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved